Summit Global Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,483
Closed -$382K 485
2024
Q4
$382K Sell
11,483
-14,100
-55% -$457K 0.02% 412
2024
Q3
$664K Sell
25,583
-8,464
-25% -$210K 0.04% 323
2024
Q2
$765K Sell
34,047
-9,817
-22% -$218K 0.05% 283
2024
Q1
$1.04M Buy
43,864
+5,406
+14% +$120K 0.08% 202
2023
Q4
$923K Buy
+38,458
New +$836K 0.06% 251
2023
Q3
Sell
-11,242
Closed -$215K 547
2023
Q2
$215K Buy
+11,242
New +$217K 0.01% 500
2023
Q1
Sell
-38,228
Closed -$613K 525
2022
Q4
$613K Buy
+38,228
New +$623K 0.05% 280
2021
Q3
Sell
-10,336
Closed -$186K 494
2021
Q2
$186K Sell
10,336
-99,764
-91% -$2.33M 0.01% 536
2021
Q1
$2.49M Buy
110,100
+31,623
+40% +$714K 0.16% 108
2020
Q4
$1.57M Sell
78,477
-87,399
-53% -$1.83M 0.16% 115
2020
Q3
$4.06M Buy
+165,876
New +$3.87M 0.42% 50

Other funds holding EXEL

Summit Global Investments's EXEL Position: Q1 2025 in Review

Summit Global Investments sold out of Exelixis (EXEL) in Q1 2025, closing a stake of 11,483 shares — an estimated $382K sold.

Summit Global Investments first reported a position in EXEL in Q3 2020 and held it in 11 quarters. The position peaked at $4.06M in Q3 2020. 557 funds tracked by Wall St. Rank hold EXEL as of Q1 2025.

  • Summit Global Investments reported no remaining Exelixis position as of Q1 2025 after selling out during the quarter.
  • Summit Global Investments sold 11,483 Exelixis shares in Q1 2025, an estimated $382K.
  • Summit Global Investments first reported a position in Exelixis in Q3 2020 and held it in 11 quarters.
  • Summit Global Investments's Exelixis position peaked at $4.06M in Q3 2020.
  • 557 funds tracked by Wall St. Rank held Exelixis as of Q1 2025.

Based on Summit Global Investments's 13F filing for Q1 2025, filed 7 Apr 2025.